Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001080879 | SCV000554238 | benign | Developmental and epileptic encephalopathy, 36 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000710504 | SCV000718283 | likely benign | not provided | 2022-09-16 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Athena Diagnostics | RCV000710504 | SCV000840740 | benign | not provided | 2018-01-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000710504 | SCV001962653 | likely benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | ALG13: BS2 |
Genome- |
RCV001080879 | SCV002524929 | benign | Developmental and epileptic encephalopathy, 36 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002451147 | SCV002738379 | likely benign | Inborn genetic diseases | 2017-09-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Diagnostic Laboratory, |
RCV000710504 | SCV001740322 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000710504 | SCV001798636 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000710504 | SCV001930767 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000710504 | SCV001975285 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004752904 | SCV005344504 | benign | ALG13-related disorder | 2024-09-25 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |